Nakamoto Inc. — Form 8-K Summary
Business context and reporting period
This current report covers events dated October 1, 2026; it was signed on October 5, 2026. Nakamoto Inc. reported changes to its warrant and transfer-agent arrangements. The filing does not describe a change to the company’s core business.
Financial and operating metrics
The filing provides no revenue, profit, cash flow, margin, debt, liquidity, or other operating-performance figures. It contains no financial statements or financial guidance.
Material changes
- Odyssey Transfer and Trust Company became the company’s warrant agent and transfer agent and registrar, effective October 1, 2026, replacing VStock Transfer, LLC. Registered common shares and related records were transferred to Odyssey.
- VStock is required to transfer warrant records and any funds or other property it holds, and to cooperate in the transition. Odyssey does not assume predecessor-agent liabilities or obligations arising before its appointment. Rights, liabilities, and obligations accrued under the prior agreement survive.
- The amended and restated warrant-agent agreement reflects the company’s name change from Kindly MD, Inc. to Nakamoto Inc., its conversion into a Delaware corporation, and the 1-for-40 reverse stock split effective May 22, 2026. It also updates registration-statement references, administrative provisions, and warrant forms.
- As of October 1, 2026, outstanding warrants are held in book-entry form through DTC and evidenced by global certificates; none are certificated.
Warrants, outlook, and risks
The filing states that the agent change and updated warrant forms do not otherwise amend the economic terms of outstanding warrants, including exercise price, shares issuable, or the June 3, 2029 expiration date; reverse-split-related adjustments are excepted. Existing warrants govern if their terms differ from the updated forms, unless amended in accordance with their terms. The filing provides no business outlook or guidance.
Key facts for investors to verify
- Review the full amended and restated warrant-agent agreement and the second addendum, including any redacted provisions.
- Confirm the applicable post-reverse-split exercise terms and share amounts for each warrant series.
- Verify completion of the transfer of warrant records, funds, and registered-share records to Odyssey.
- Check the company’s registration statement and subsequent filings for information relevant to registration and resale of shares issuable upon warrant exercise.